India's Shilpa Medicare gains after over 11-fold rise in Q2 profit
14/11/2024 05:02
** Shares of Shilpa Medicare SHME.NS rise 6.7% to 880
rupees, their biggest one-day gain since Oct. 8
** Pharma co's Q2 consol profit and revenue rises over
11-fold and 13%, respectively, helped by traction in its
emerging markets and formulation segment
** SHME sees third-busiest day in nearly three months, with
over 391,000 shares traded
** Stock extends YTD gains to 166% vs 122% gain in peer
Solara Active Pharma SOLA.NS
(Reporting by Aleef Jahan in Bengaluru)
((aleefjahan.cs@thomsonreuters.com))
Recent news on Shilpa Medicare
See all newsBrief: Shilpa Medicare Q2 Consol Net Profit INR 791.8 Million
Brief: Shilpa Medicare Says USFDA Conducts Surveillance Inspection At Shilpa Medicare Unit
Brief: Shilpa Medicare Receives Final SEC Approval For Oeris Marketing Authorization
India's Shilpa Medicare gains on approval for OERIS
Brief: Shilpa Medicare Initiates Voluntary Recall Of 27,923 Pemetrexed Injection Vials In Us On July 29, 2026